Cookie Settings

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info

Made by Flinch 77

Oops! Something went wrong while submitting the form.

Building Breakthrough AI-Driven SaMD Products

New Moments of Care

Intelligent screening designed to identify and improve care for individuals at risk.

User-Centric Design

AI software that seamlessly integrates into existing clinical practice & workflows.

Value-based Model of Care

Improve healthcare quality & increase revenue through intelligent screening.

RhoTM

AI-driven opportunistic screening to improve population bone health.

Rho utilizes routinely captured x-rays to opportunistically identify patients at risk of osteoporosis.
‍

Licensed by Health Canada

FDA De Novo Marketing Authorization

Explore RhoTM→

request a Demo→

Osteoporosis Care Reimagined

Impacting care through AI-driven opportunistic screening.

Only

1 in 4

eligible women are currently screened for osteoporosis.

Up-to

50%

of men are never screened for osteoporosis.

RhoTM can utilize

60 - 80%

of x-rays captured during routine care.

Number of individuals with low BMD:

42 million

potential lives impacted.

PhysisTM

AI-Driven smart atlas for bone age estimation.

Bone age assessments are one of the most cumbersome imaging procedures performed in children. Physis is an award-winning software that revolutionizes bone age assessment.

Try PhysisTM